Prosecution Insights
Last updated: April 19, 2026

NovMetaPharma Co., Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17612038 USE OF COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BONE LOSS DISORDERS, COMPRISING CYCLO-HISPRO (CHP) AND PARATHYROID HORMONE LEE, JIA-HAI 1658 Final Rejection Nov 17, 2021
17406626 METHOD FOR TREATING INFLAMMATORY BOWEL DISEASES ESPINOSA, CLAUDIA EDILMA 1654 Final Rejection Aug 19, 2021

Managing NovMetaPharma Co., Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month